Arkema sells to Taminco its Specialty Amines business in North America
Arkema announces the sale to Taminco of its Specialty amines activity produced in the Riverview (Michigan) facility. Part of the Thiochemicals business unit, this activity generates sales of some $ 72 M. This divestment is part of Arkema's strategy for a selective management of its asset portfolio.
At the end of 2005, Arkema began restructuring its Riverview operations in the US with the closure of sulfonyls and commodity amines production plants and the site's re-centering on specialty amines, which became profitable again in 2006.
Arkema has now decided to sell this non-strategic activity to Taminco, whose core business is the production of amines and derivatives. This acquisition shall enable Taminco to bolster its industrial facilities in the United States with the Riverview site, and expands its product line.
The deal is part of the transformation drive initiated by Arkema at the time of its creation, and represents a further step in its portfolio re-centering process.
Other news from the department business & finance
